The CDC’s Advisory Committee on Immunization Practices on Wednesday unanimously recommended (15-0) three flu vaccines for adults over the age of 65: Seqirus’s Fluad and Sanofi’s Fluzone and Flublok. Flublok was originally developed by Protein Sciences, which then become Sanofi’s when the Big Pharma acquired the company in 2017 for $650 million upfront and $100 million more in milestones.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,